Ikarian Capital »

Finch Therapeutics Group shares owned by Ikarian Capital

Quarter-by-quarter ownership of Finch Therapeutics Group (FNCH) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Finch Therapeutics Group

Tip: Access up to 7 years of quarterly data

All positions including Finch Therapeutics Group held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Finch Therapeutics Group by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $25k 6.9k 3.61
2023-09-30 $35k 6.9k 5.10
2023-06-30 $68k 7.9k 8.53

More positions owned by Ikarian Capital

Argenx Se Sponsored Adr (ARGX)
Krystal Biotech Call Option (KRYS)
Cytokinetics Com New (CYTK)
Alnylam Pharmaceuticals Call Option (ALNY)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Crispr Therapeutics Namen Akt (CRSP)
Eli Lilly & Co. Put Option (LLY)
Sarepta Therapeutics (SRPT)
Prothena Corp SHS Call Option (PRTA)
Amylyx Pharmaceuticals (AMLX)
Nuvalent Inc-a (NUVL)
Immunovant (IMVT)
Crinetics Pharmaceuticals In (CRNX)
Soleno Therapeutics (SLNO)
Eyepoint Pharmaceuticals Com New (EYPT)

View all positions for Ikarian Capital

Top funds holding Finch Therapeutics Group

Vanguard Group
Ikarian Capital
Bleichroeder
Royal Bank of Canada
Bank of America Corporation
Wells Fargo & Company
UBS Group

View all funds holding Finch Therapeutics Group